Pharmacokinetic Properties of Idalopirdine (Lu AE58054) in Subjects With and Without Impaired Kidney Function
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics properties of idalopirdine
following multiple dosing in patients with renal impairment and compare to those in healthy
subjects